IP Library Granted Patent US 7,879,605
Granted Patent B2
US 7,879,605 · App. 12/562,767 · Granted Feb 1, 2011

Methods and compositions for tissue regeneration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,605
App. No.
12/562,767
Granted
Feb 1, 2011
Kind
B2
Abstract

Disclosed is a composition comprising cells comprising keratinocytes or fibroblasts, or mixtures thereof, that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGFβ, angiopoietin, EGF, IL-ID, IL- 6 , IL- 8 , TGFα, and TNFα and an extracellular matrix comprising alginate, wherein the cells are allogeneic and mitotically inactive.

Claims (17)

1. A composition comprising:

(a) cells comprising keratinocytes or fibroblasts, or mixtures thereof, that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGFβ, angiopoietin, EGF, IL-Iβ, IL-6, IL-8, TGFα, and TNFα;

(b) an extracellular matrix comprising alginate;

(c) a buffered solution; and

(d) human serum albumin or a cryoprotectant,

wherein the cells are allogeneic and mitotically inactive.

2. The composition of claim 1 , wherein the cells are mitotically inactivated by irradiation.

3. The composition of claim 1 , wherein the composition comprises keratinocytes and fibroblasts and the ratio of keratinocytes to fibroblasts is 1:9.

4. The composition of claim 1 , wherein the composition is a paste.

5. The composition of claim 1 , wherein the composition comprises human serum albumin and a cryoprotectant.

6. The composition of claim 1 , wherein the buffered solution is HBSS.

7. The composition of claim 1 , wherein the buffered solution comprises Ca ++ .

8. The composition of claim 1 , wherein the composition comprises human serum albumin.

9. The composition of claim 1 , wherein the composition comprises a cryoprotectant.

10. The composition of claim 9 wherein the cryoprotectant is glycerol.

11. The composition of claim 9 , wherein the composition is cyropreserved.

12. The composition of claim 9 , wherein the composition is comprised in a sterile vial.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2015
From: ROLLAND, ERIC; HUNZIKER, THOMAS; CHEVALLAY, BEATRICE; RINSCH, CHRISTOPHER
To: ISOTIS SA
Reel/Frame 036219/0826 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2015
From: ISOTIS SA
To: EPISOURCE SA
Reel/Frame 036220/0155 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2015
From: EPISOURCE SA
To: DFB PHARMACEUTICALS, INC.
Reel/Frame 036220/0553 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2013
From: HEALTHPOINT INTERNATIONAL, LLC
To: SMITH & NEPHEW, INC.
Reel/Frame 029994/0633 →
CHANGE OF NAME Recorded Dec 17, 2012
From: DFB TECHNOLOGY HOLDINGS, LLC; HEALTHPOINT HOLDINGS, LLC
To: HEALTHPOINT INTERNATIONAL, LLC
Reel/Frame 029481/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2010
From: DFB PHARMACEUTICALS, INC.
To: DFB TECHNOLOGY HOLDINGS, LLC
Reel/Frame 023788/0443 →